No association between IL-1β -511 C/T polymorphism and the risk of duodenal ulcer: A meta-analysis of 4667 subjects

Gene

Volumn 506, Issue 1, 2012, Pages 188-194

  Zhang, Bei Bei ^a   Yin, Yan Wei ^b   Sun, Qian Qian ^c  

^a General Hospital of PLA Chengdu Military Area Command   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

^c Jinsong Sanatorium of Beijing Air Force   (China)

Author keywords

Duodenal ulcer; Interleukin 1 ; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 1BETA;

ALLELE; ARTICLE; DNA POLYMORPHISM; DUODENUM ULCER; EMBASE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENOTYPE; HELICOBACTER INFECTION; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; SENSITIVITY ANALYSIS;

ALLELES; CASE-CONTROL STUDIES; DUODENAL ULCER; GENES, DOMINANT; GENES, RECESSIVE; GENETIC ASSOCIATION STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-1BETA; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

HELICOBACTER PYLORI;

EID: 84864524701     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.06.058     Document Type: Article

References (38)

1. Beales I.L., Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998, 42:227-234.
2. Chakravorty M., Ghosh A., Choudhury A., Santra A., Hembrum J., Roychoudhury S. Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum. Mutat. 2006, 27:411-419.
3. Chang Y.W., et al. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes. Scand. J. Gastroenterol. 2008, 43:1184-1193.
4. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
5. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
6. di Giovine F.S., Takhsh E., Blakemore A.I., Duff G.W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum. Mol. Genet. 1992, 1:450.
7. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
8. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
9. Erzin Y., et al. Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia. J. Gastroenterol. 2008, 43:705-710.
10. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002, 123:92-105.
11. García-González M.A., et al. Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin. Exp. Immunol. 2003, 134:525-531.
12. Garcia-Gonzalez M.A., et al. No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease. Int. J. Immunogenet. 2005, 32:299-306.
13. Go M.F. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2002, 16:3-15.
14. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
15. Hsu P.I., et al. The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer. Helicobacter 2004, 9:605-613.
16. Hwang I.R., et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002, 123:1793-1803.
17. Kim N., et al. The effects of genetic polymorphisms of IL-1 and TNF-A on Helicobacter pylori-induced gastroduodenal diseases in Korea. Helicobacter 2006, 11:105-112.
18. Lewis C.M. Genetic association studies: design, analysis and interpretation. Brief. Bioinform. 2002, 3:146-153.
19. Li C., et al. Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population. J. Gastroenterol. Hepatol. 2007, 22:234-239.
20. Lindholm C., Quiding-Järbrink M., Lönroth H., Hamlet A., Svennerholm A.M. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 1998, 66:5964-5971.
21. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
22. Mei Q., et al. Associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease in Chinese Han population. Int. J. Immunogenet. 2010, 37:9-12.
23. Melo Barbosa H.P., et al. Interleukin-1 and TNF-alpha polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J. Gastroenterol. 2009, 15:1465-1471.
24. Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 2009, 151:264-269.
25. Nicklin M.J., Weith A., Duff G.W. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994, 19:382-384.
26. Noach L.A., Bosma N.B., Jansen J., Hoek F.J., van Deventer S.J., Tytgat G.N. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 1994, 29:425-429.
27. Pociot F., Mølvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 1992, 22:396-402.
28. Queiroz D.M., Bittencourt P., Guerra J.B., Rocha A.M., Rocha G.A., Carvalho A.S. IL1RN polymorphism and cagA-positive Helicobacter pylori strains increase the risk of duodenal ulcer in children. Pediatr. Res. 2005, 58:892-896.
29. Robert A., Olafsson A.S., Lancaster C., Zhang W.R. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci. 1991, 48:123-134.
30. Robert A., et al. Gastric cytoprotection by intracisternal interleukin-1 beta in the rat. Biochem. Biophys. Res. Commun. 1991, 174:1117-1124.
31. Shin W.G., et al. Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea. J. Gastroenterol. Hepatol. 2008, 23:1567-1573.
32. Sugimoto M., et al. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J. Gastroenterol. Hepatol. 2007, 22:51-59.
33. Vincenzi B., et al. Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. Oncol. Rep. 2008, 20:1213-1220.
34. Wallace J.L., Cucala M., Mugridge K., Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am. J. Physiol. 1991, 261:G559-G564.
35. Wells G.A., et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses 2011, Ottawa Health Research Institute, www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
36. Wolfe M.M., Nompleggi D.J. Cytokine inhibition of gastric acid secretion-a little goes a long way. Gastroenterology 1992, 102:2177-2178.
37. Yin Y.W., et al. Association between interleukin-6 gene -174 G/C polymorphism and the risk of coronary heart disease: a meta-analysis of 20 studies including 9619 cases and 10,919 controls. Gene 2012, 503:25-30.
38. Zhang H., Bi Y., Hu C., Lu W., Zhu D. Association between the Pro12Ala polymorphism of PPAR-γ gene and the polycystic ovary syndrome: a meta-analysis of case-control studies. Gene 2012, 503:12-17.